CommercialCoverageMedium impact
Powered Exoskeleton for Ambulation in Patients With Lower-Limb Disabilities
Blue Cross & Blue Shield of Mississippi·MS · PM&R (Physical Medicine & Rehab), Neurology, Orthopedics +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has established a new medical policy (A.1.03.04) classifying powered exoskeletons for ambulation in patients with lower-limb disabilities as investigational, meaning these devices are not covered. This affects billing for FDA-approved devices like ReWalk, Indego, Ekso, and other powered exoskeletons used for mobility assistance in spinal cord injury, stroke, and other neurological conditions.
Action Required
Immediately: Billing team must flag all powered exoskeleton claims as non-covered investigational services for BCBS Mississippi members. Update billing system to deny authorization requests for powered exoskeletons (ReWalk, Indego, Ekso, HAL, etc.). Inform providers that these devices are considered investigational and not covered except for Federal Employee Program (FEP) members where medical necessity may still apply.